Finance

Beta
Lists
MMQ0:FRA
Definium Therapeutics Inc
€19.60
-1.26%
(-0.25) 1D
May 29, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MMQ0...
Open
€19.60
High
€19.60
Low
€19.60
Mkt. cap
2.64B
Avg. vol.
515.00
Volume
0.00
52-wk high
€23.00
52-wk low
€12.81
No. of employees
106
Open
€19.60
High
€19.60
Low
€19.60
Mkt. cap
2.64B
Avg. vol.
515.00
Volume
0.00
52-wk high
€23.00
52-wk low
€12.81
No. of employees
106
News stories
From sources across the web
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
29.81M
30.98M
33.52M
41.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.09M
14.69M
14.06M
17.74M
Operating expense
40.90M
45.67M
47.58M
59.22M
Total operating expenses
40.90M
45.67M
47.58M
59.22M
Operating income
-40.90M
-45.67M
-47.58M
-59.22M
Other non operating income
-2.23M
-22.54M
-5.06M
-20.05M
EBT including unusual items
-42.74M
-67.26M
-50.44M
-77.10M
EBT excluding unusual items
-42.74M
-67.26M
-50.44M
-77.10M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-42.74M
-67.26M
-50.44M
-77.10M
Net profit margin
-
-
-
-
Earnings per share
-0.50
-0.78
-
-0.71
Interest and investment income
2.77M
2.26M
3.49M
3.46M
Interest expense
-2.34M
-1.27M
-1.27M
-1.24M
Net interest expenses
436.00K
988.00K
2.22M
2.21M
Depreciation and amortization charges
-
-
-
-
EBITDA
-40.90M
-45.66M
-47.57M
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer